Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Study Overview Amgen is launching a Phase 3 trial ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways Vitamin B3 supplementation may improve cholesterol levels, but it ...

As you age, your doctor’s interest in your cholesterol level is likely to increase. That’s no coincidence. High cholesterol ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared a new lipoprotein assay designed to measure lipoprotein(a) in nmol/L. Measuring nmol/L rather ...

Lipoprotein(a) has been studied as a risk factor for coronary heart disease, but whether a causal relationship exists has been unclear. A study by Kamstrup and colleagues examining genetically ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be untreatable, for up to one year. Lipoprotein(a) is a type of cholesterol that ...

Following these positive 36-week results, Silence Therapeutics plans to announce 48-week results of the ongoing ALPACAR-360 study in Q2 of 2024. Silence Therapeutics has released promising findings ...

All sex, race, and risk category groups appeared to be affected by the heart disease risk posed by elevated lipoprotein(a), or Lp(a), according to pooled analysis of primary prevention studies.